UNSPSC 51322504: Draquinolol

This classification denotes a beta-adrenergic blocking agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier K3B3L3Q0GV. European Medicines Agency schedules Draquinolol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06397MIG. Draquinolol generally arises in the molecular formula C24H30N2O4.

UNSPSC 51322504 Draquinolol is a Commodity code reflecting emergency and acute-care pharmaceuticals actually being procured by state and local emergency services and pharmacy benefit programs. The City of Tampa's Fire Rescue department solicited Advanced Life Support Medications including epinephrine, labetalol, adenosine, and diltiazem via sealed bid (IFB 26P00188, due April 8, 2026) with an estimated contract value of $40,000; the Texas Health and Human Services Commission issued a Request for Information on direct-to-manufacturer prescription fulfillment models (RFI HHS0017013, closed April 3, 2026) to explore pharmacy benefit optimization across state employee and health plan populations; and the Minnesota Multistate Cooperative Purchasing Alliance issued an RFP for generic multi-source pharmaceuticals and OTC products (S1070000015802, due March 26, 2026) for distribution across state and local government facilities in Minnesota and Oregon. Issuing bodies span municipal fire departments, state health and human services commissions, and multistate cooperative purchasing alliances serving participating state and local agencies.

Recent activity is concentrated in Florida, Texas, and Minnesota. The Tampa Fire Rescue solicitation reflects routine emergency-medicine supply replenishment with firm pricing, nine-month minimum expiration warranties, and one-year terms with renewal options; the Texas HHS RFI signals state-level strategic exploration of direct manufacturer relationships outside traditional pharmacy benefit manager and group purchasing organization channels, with no immediate procurement timeline or budget allocation; and the MMCAP cooperative RFP demonstrates multistate purchasing scale for generic pharmaceuticals distributed through three authorized wholesalers (AmerisourceBergen/Cencora, Cardinal Health, Morris & Dickson) with two-year contract terms, cGMP and Drug Supply Chain Security Act compliance requirements, and pricing weighted 75 percent in evaluation. SLBE set-asides and sheltered-market designations appear in municipal solicitations; no set-aside restrictions are noted in the state RFI or cooperative RFP materials reviewed.